Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy's official step-by-step injection guidance, published by the NHS and Novo Nordisk, shows the process takes under a minute once you've done it a few times — but the first injection often feels daunting, and that's completely normal. This guide walks you through each stage of Wegovy application in plain language, explaining what the evidence and clinical guidance say about technique, site rotation, and the small details that make a real difference to comfort and effectiveness. Wegovy (semaglutide) is a prescription-only medicine; your prescriber and the Patient Information Leaflet included with your pen are your authoritative sources for dosing decisions.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The NHS medicines guidance for semaglutide emphasises that subcutaneous injection technique directly affects both comfort and how reliably the medicine is absorbed. The STEP 1 trial, published in the New England Journal of Medicine, recorded an average body-weight reduction of around 15% over 68 weeks at the 2.4 mg maintenance dose, and that evidence was built on participants using correct, consistent injection technique throughout. Sloppy form doesn't just sting more; it can affect what your body actually receives.
The pre-filled Wegovy pen is designed to make this straightforward. There's no needle to attach, no dial to turn, and no plunger to press. You choose your site, hold the pen flat against clean skin, press and hold, and the pen does the rest. The covered needle retracts automatically once the dose is complete, which removes one of the most common sources of anxiety for people new to self-injection. A full walkthrough of how the Wegovy pen works in practice covers the sequence frame by frame.
One misconception worth gently clearing up: many people assume they need to pinch the skin into a fold before injecting, the way older insulin techniques required. For the Wegovy pen, this isn't necessary on the abdomen or thigh for most adults, the needle length and automatic mechanism are calibrated for flat, unpinched skin. Check your Patient Information Leaflet or ask your prescriber if you're unsure for your specific situation.
Three sites are licensed for Wegovy: the abdomen (belly), the outer thigh, and the outer upper arm. Each has practical advantages. The abdomen is the easiest to see and reach yourself. The thigh is a natural choice if the abdomen feels sensitive in early weeks. The upper arm works well but generally requires a second person to assist, or a steady wall to brace against.
Rotation matters. Using the same small patch of skin week after week can cause localised thickening called lipohypertrophy, which not only feels uncomfortable but can reduce how predictably the medicine is absorbed. The simplest system is to divide each site into quadrants and move around them systematically, rather than aiming for the same spot out of habit.
Avoid skin that is bruised, scarred, or irritated. Clean the area with an approach that suits your skin, an alcohol swab is standard, left to dry for a few seconds before injecting. Inject at a 90-degree angle, straight in, rather than at a slant.
If you've ever left a pen out of the fridge and wondered whether it's still safe to use, the guidance on Wegovy storage covers exactly what to do, storage windows are stricter than many people realise, and this is one situation where your Patient Information Leaflet gives the definitive answer rather than a general rule.
Most Wegovy application videos, including those published by Novo Nordisk UK, cover the core steps clearly: removing the pen from its packaging, checking the liquid, positioning against the skin, and the two-click sequence. What they cover less thoroughly are the questions people actually have after their first injection.
Why did I bleed a little? A tiny amount of bleeding at the injection site is normal, a small capillary occasionally gets nicked, and it doesn't mean you've done anything wrong or that the dose was lost. Press gently with a clean piece of cotton for a few seconds.
Why didn't I hear the second click? This occasionally happens if the pen isn't held completely flat and firm against the skin. Keep steady pressure throughout. If you're uncertain whether the full dose was delivered, your prescriber is the right person to ask, don't re-inject without clinical guidance.
Can I inject through clothing? The clinical guidance and manufacturer instructions say no; inject through clean exposed skin. It's worth knowing that the Wegovy use video from Novo Nordisk specifically demonstrates this step.
For a broader look at how semaglutide works and what the treatment journey involves, the semaglutide overview is a useful companion to the injection technique guidance.
Injection-site reactions (mild redness, brief soreness, occasional itching) are common and usually settle within a day. The full side-effect profile for Wegovy is led by gastrointestinal symptoms: nausea is the most frequently reported, particularly in the weeks after starting or after a dose increase. Most people find it eases as the body adjusts.
More serious symptoms require prompt medical attention. Severe, persistent stomach pain that reaches through to the back (with or without vomiting) should be assessed urgently; it can be a sign of pancreatitis, which the MHRA highlighted in a Drug Safety Update in January 2026 as an infrequent but serious risk with GLP-1 medicines. Symptoms of an allergic reaction (swelling of the face, difficulty breathing, rapid heartbeat) are also a reason to call 999 or go to A&E.
If you have questions about side effects or technique after starting treatment, our prescribers are available seven days a week. And if you're still working out whether Wegovy is the right route for you, the full Wegovy overview covers eligibility, the evidence, and what private treatment involves, including a sense of what Wegovy costs in the UK private market. When you're ready, you can check your eligibility with a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.